Gene transfer of CD40-ligand induces autologous immune recognition of chronic lymphocytic leukemia B cells

被引:184
|
作者
Kato, K
Cantwell, MJ
Sharma, S
Kipps, TJ
机构
[1] Univ Calif San Diego, Sch Med, Dept Med, Div Hematol Oncol, La Jolla, CA 92093 USA
[2] Univ Calif San Diego, Sch Med, Human Gene Therapy Program, La Jolla, CA 92093 USA
来源
JOURNAL OF CLINICAL INVESTIGATION | 1998年 / 101卷 / 05期
关键词
CD40-ligand; leukemia; antigen presentation; immune activation; gene therapy;
D O I
10.1172/JCI1472
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
CD40-CD40-ligand (CD154) interactions play a critical role in immune activation, Using replication defective adenovirus encoding mouse CD154 (Ad-CD154), we modified human chronic lymphocytic leukemia B cells to express a functional ligand for CD40. This not only induces expression of immune accessory molecules on the infected cell, but also allows it to trans-activate noninfected bystander leukemia B cells, Also, factors that impair the antigen-presenting capacity of leukemia B cells are downmodulated. Ad-CD154-infected leukemia cells are highly effective stimulators in mixed lymphocyte reactions and can induce generation of cytotoxic T lymphocytes specific for autologous nonmodified leukemia cells, As such, Ad-CD154 can induce a host antileukemia response that may have therapeutic potential.
引用
收藏
页码:1133 / 1141
页数:9
相关论文
共 50 条
  • [1] Adenovirus-mediated gene transfer of CD40-ligand induces autologous immune recognition of chronic lymphocytic leukemia B cells.
    Kato, K
    Cantwell, MJ
    Sharma, S
    Kipps, TJ
    BLOOD, 1997, 90 (10) : 1157 - 1157
  • [2] CD40-ligand (CD154) gene therapy for chronic lymphocytic leukemia
    Wierda, WG
    Cantwell, MJ
    Woods, SJ
    Rassenti, LZ
    Prussak, CE
    Kipps, TJ
    BLOOD, 2000, 96 (09) : 2917 - 2924
  • [3] CD40-ligand (CD154) gene therapy for chronic lymphocytic leukemia
    Kipps, TJ
    Wierda, WG
    Cantwell, MJ
    Woods, SJ
    Rassenti, LZ
    Prussak, CE
    CANCER GENE THERAPY, 2000, 7 (12) : S16 - S16
  • [4] Acquired CD40-ligand deficiency in chronic lymphocytic leukemia
    Mark Cantwell
    Tinh Hua
    Jim Pappas
    Thomas J. Kipps
    Nature Medicine, 1997, 3 : 984 - 989
  • [5] Acquired CD40-ligand deficiency in chronic lymphocytic leukemia
    Cantwell, M
    Hua, T
    Pappas, J
    Kipps, TJ
    NATURE MEDICINE, 1997, 3 (09) : 984 - 989
  • [6] CD154 (CD40-ligand) gene immunization of chronic lymphocytic leukemia: A phase I study.
    Wierda, WG
    Cantwell, MJ
    Rassenti, LZ
    Avery, E
    Johnson, TA
    Kipps, TJ
    BLOOD, 1998, 92 (10) : 489A - 489A
  • [7] A phase I study of CD154 (CD40-ligand) gene therapy for chronic lymphocytic leukemia.
    Wierda, WG
    Rassenti, LZ
    Cantwell, MJ
    Woods, SJ
    Kipps, TJ
    BLOOD, 1999, 94 (10) : 602A - 602A
  • [8] Intercellular transfer of functional CD40-ligand on B cells.
    Gutjahr, TS
    Cantwell, MJ
    Tsukada, N
    Kipps, TJ
    BLOOD, 2001, 98 (11) : 23A - 23A
  • [9] Autologous antileukemic immune response induced by chronic lymphocytic leukemia B cells expressing the CD40 ligand and interleukin 2 transgenes
    Takahashi, S
    Rousseau, RF
    Yotnda, P
    Mei, ZY
    Dotti, G
    Rill, D
    Hurwitz, R
    Marini, F
    Andreeff, M
    Brenner, MK
    HUMAN GENE THERAPY, 2001, 12 (06) : 659 - 670
  • [10] Comparison of two CD40-ligand/interleukin-2 vaccines in patients with chronic lymphocytic leukemia
    Okur, Fatma Visal
    Yvon, Eric
    Biagi, Ettore
    Dotti, Gianpietro
    Carrum, George
    Heslop, Helen
    Mims, Martha P.
    Fratantoni, Joseph C.
    Peshwa, Madhusudan V.
    Li, Linhong
    Brenner, Malcolm K.
    CYTOTHERAPY, 2011, 13 (09) : 1128 - 1139